Keyphrases
Isogenic mutant
100%
Envelope Structure
100%
Human Infection
83%
Neisseria Gonorrhoeae
83%
Urethral Infection
62%
Gonorrhea
62%
Vaccine Target
41%
Human Cells
41%
Antimicrobial
41%
Cell Systems
41%
Innate Immune Response
41%
Cell Envelope
25%
GC Cells
25%
Male Volunteers
25%
Non-competitive
25%
MtrCDE Efflux Pump
25%
Bacterial Structure
25%
GC Resistance
20%
New Drug Targets
20%
Innate Immune Cells
20%
University of North Carolina
20%
Mouse Model
20%
Host Immune Response
20%
Antimicrobial Therapy
20%
Next-generation Vaccines
20%
Molecular Mechanism
20%
Gene Expression
20%
Inflammation
20%
New Antimicrobials
20%
Attendants
20%
Public Health Risk
20%
Host Response
20%
Clinical Trials
20%
Peptidoglycan
20%
Global Public Health
20%
Surface Structure
20%
Antibiotic Resistance
20%
Expected Outcomes
20%
Potential Therapeutics
20%
Lipids
20%
Genital Infection
20%
Human Immune System
20%
HIV Transmission
20%
Gonococcal Infection
20%
Adverse Health Consequences
20%
GC Gene
20%
Infectivity
20%
Immunology and Microbiology
Neisseria gonorrhoeae
83%
Vaccine Efficacy
83%
Urethritis
62%
Mouse
41%
Innate Immune System
41%
Immune Response
41%
Human Cell
41%
Wild Type
41%
Bacterial Structures
25%
Surface Property
20%
Gene Expression
20%
Antimicrobial Resistance
20%
Host Immune Response
20%
Peptidoglycan
20%
Human Immunodeficiency Virus
20%
Immunocompetent Cell
20%
Mouse Model
20%